Cyclooxygenase-2 expression is associated with VEGF-C and lymph node metastases in gastric cancer patients.

[1]  P. Kyzas,et al.  COX-2 expression correlates with VEGF-C and lymph node metastases in patients with head and neck squamous cell carcinoma , 2005, Modern Pathology.

[2]  B. Aggarwal,et al.  Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates activation of cigarette smoke-induced nuclear factor (NF)-kappaB by suppressing activation of IkappaBalpha kinase in human non-small cell lung carcinoma: correlation with suppression of cyclin D1, COX-2, and matrix metalloproteinase-9. , 2004, Cancer research.

[3]  Bingya Liu,et al.  Vascular Endothelial Growth Factor C Expression in Gastric Carcinoma and Its Relationship with Lymph Node Metastasis , 2004 .

[4]  M. Osaki,et al.  Cyclooxygenase-2 expression in human gastric tubular adenomas and carcinomas; correlation with intratumoral microvessel density and apoptotic index. , 2004, Anticancer research.

[5]  M. McCarter,et al.  Lymphangiogenesis is pivotal to the trials of a successful cancer metastasis. , 2004, Surgery.

[6]  J. Shih,et al.  Cyclooxygenase-2 Induces EP1- and HER-2/Neu-Dependent Vascular Endothelial Growth Factor-C Up-Regulation , 2004, Cancer Research.

[7]  T. Saito,et al.  Lymph node metastasis as a significant prognostic factor in gastric cancer: a multiple logistic regression analysis , 2004, Scandinavian journal of gastroenterology.

[8]  K. Wester,et al.  HER-2, EGFR, COX-2 expression status correlated to microvessel density and survival in resected non-small cell lung cancer. , 2004, Acta oncologica.

[9]  K. Komiyama,et al.  Immunohistochemical detection of human small lymphatic vessels under normal and pathological conditions using the LYVE-1 antibody , 2004, Virchows Archiv.

[10]  K. Hatakeyama,et al.  Vascular endothelial growth factor-C and vascular endothelial growth factor-d messenger RNA expression in breast cancer: association with lymph node metastasis. , 2003, Clinical breast cancer.

[11]  C. Buskens,et al.  Cyclooxygenase‐2 and gastric carcinogenesis , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[12]  W. Jiang,et al.  Quantitative analysis of lymphangiogenic markers in human colorectal cancer. , 2003, International journal of oncology.

[13]  S. Nathanson,et al.  Insights into the mechanisms of lymph node metastasis , 2003, Cancer.

[14]  Zenta Walther.  COX-2 and angiogenesis in gastric cancer. , 2003, Journal of clinical gastroenterology.

[15]  A. Saaristo,et al.  Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck , 2003, Head & neck.

[16]  S. Stacker,et al.  The role of tumor lymphangiogenesis in metastatic spread , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  J. Reis-Filho,et al.  Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. , 2002, Journal of clinical pathology.

[18]  M. Detmar,et al.  An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype , 2002, The EMBO journal.

[19]  Li Zhu,et al.  Non-small Cell Lung Cancer Cyclooxygenase-2-dependent Invasion Is Mediated by CD44* , 2001, The Journal of Biological Chemistry.

[20]  D. Jackson,et al.  LYVE-1, the lymphatic system and tumor lymphangiogenesis. , 2001, Trends in immunology.

[21]  M. Korc,et al.  Overexpression of Lymphangiogenic Growth Factor VEGF-C in Human Pancreatic Cancer , 2001, Pancreas.